Moors & Cabot Inc. cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,997 shares of the biopharmaceutical company’s stock after selling 3,294 shares during […]